AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17643572 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin alone (single therapy), placebos for ER-niacin and colesevelam
Number of subjects: 123
Study 17643572 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin plus ER-niacin (2 g/d), placebo for colesevelam (double therapy)
Number of subjects: 123
Study 17643572 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin, ER-niacin, plus colesevelam (3.8 g/d) (triple therapy)
Number of subjects: 123
Study 17643572 — intervention group
Group type: COMPARATOR
Intervention: Placebo for ER-niacin and colesevelam (single therapy)
Number of subjects: 123
Study 15330199 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen A (Mitomycin, Cisplatin, and Doxifluridine)
Number of subjects: 61
Study 15330199 — intervention group
Group type: COMPARATOR
Intervention: Regimen B (Cisplatin and Doxifluridine)
Number of subjects: 61
Study 11241303 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 918
Study 9260213 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice water ingestion (250 ml of 0‐4 degrees C)
Number of subjects: 60
Study 9260213 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm water ingestion (250 ml of 25 degrees C)
Number of subjects: 60
Study 9260213 — intervention group
Group type: COMPARATOR
Intervention: Ice water ingestion in healthy controls (23 children)
Number of subjects: 60
Study 7671682 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic exercise and supination shoe insert
Number of subjects: 469
Study 7671682 — intervention group
Group type: COMPARATOR
Intervention: Control group of not treated children
Number of subjects: 469
Study 3812435 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention to improve water-sanitation behaviors
Number of subjects: 1940
Study 3812435 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 1940
Study 3812435 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention to improve handwashing practices
Number of subjects: 1940
Study 31479075 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Couples Intervention (TCI)
Number of subjects: 150
Study 31479075 — intervention group
Group type: COMPARATOR
Intervention: Wait-listed control
Number of subjects: 150
Study 30354231 — intervention group
Group type: EXPERIMENTAL
Intervention: Heme arginate 1 mg/kg
Number of subjects: 24
Study 30354231 — intervention group
Group type: EXPERIMENTAL
Intervention: Heme arginate 3 mg/kg
Number of subjects: 24
Study 30354231 — intervention group
Group type: EXPERIMENTAL
Intervention: Heme arginate infusion
Number of subjects: 24
Study 30354231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 27419812 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Pre-Exposure Prophylaxis (PrEP)
Number of subjects: 3226
Study 27419812 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk participants
Number of subjects: 3226
Study 24606105 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop insulin delivery
Number of subjects: 12
Study 24606105 — intervention group
Group type: COMPARATOR
Intervention: Usual anti-hyperglycemic therapy
Number of subjects: 12
Study 22915615 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumour necrosis factor inhibitor
Number of subjects: 221
Study 22915615 — intervention group
Group type: EXPERIMENTAL
Intervention: ASDAS
Number of subjects: 221
Study 22915615 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP
Number of subjects: 221
Study 20552282 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic advance to the next question with no opportunity to go back (auto/no back)
Number of subjects: 807
Study 20552282 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic advance to the next questions with an opportunity to go back (auto/back)
Number of subjects: 807
Study 20552282 — intervention group
Group type: EXPERIMENTAL
Intervention: Next button to go to the next question with no opportunity to go back (next/no back)
Number of subjects: 807
Study 20552282 — intervention group
Group type: EXPERIMENTAL
Intervention: Next button to go to the next question with an opportunity to go back (next/back)
Number of subjects: 807
Study 20552282 — intervention group
Group type: COMPARATOR
Intervention: Next button (any variant)
Number of subjects: 807
Study 19126893 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic capsular release including release of the long head of the biceps tendon
Number of subjects: 88
Study 19126893 — intervention group
Group type: COMPARATOR
Intervention: Capsular release alone (Control group)
Number of subjects: 88
Study 16948965 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 0
Study 16948965 — intervention group
Group type: COMPARATOR
Intervention: Topical salicylate
Number of subjects: 0
Study 16948965 — intervention group
Group type: COMPARATOR
Intervention: Duct tape
Number of subjects: 0
Study 16948965 — intervention group
Group type: COMPARATOR
Intervention: CO2 laser
Number of subjects: 0
Study 16948965 — intervention group
Group type: COMPARATOR
Intervention: Photodynamic therapy
Number of subjects: 0
Study 16948965 — intervention group
Group type: COMPARATOR
Intervention: Pulsed dye laser (PDL)
Number of subjects: 0
Study 16948965 — intervention group
Group type: COMPARATOR
Intervention: Er:Yag laser therapies
Number of subjects: 0
Study 12825127 — intervention group
Group type: EXPERIMENTAL
Intervention: Propagermanium
Number of subjects: 0
Study 11177200 — intervention group
Group type: EXPERIMENTAL
Intervention: Wholemeal rye bread
Number of subjects: 39
Study 11177200 — intervention group
Group type: COMPARATOR
Intervention: White wheat bread
Number of subjects: 39
Study 8795326 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.04 mg.kg‐1) and Alfentanil (10 micrograms.kg‐1) followed by Propofol (1.25 mg.kg‐1)
Number of subjects: 90
Study 8795326 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (10 micrograms.kg‐1) followed by Propofol (1.25 mg.kg‐1)
Number of subjects: 90
Study 8795326 — intervention group
Group type: COMPARATOR
Intervention: Propofol only (2.5 mg.kg‐1)
Number of subjects: 90
Study 1621413 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal aerosol administration of quadrivalent inactivated split influenza vaccine
Number of subjects: 46
Study 1621413 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous administration of quadrivalent inactivated split influenza vaccine
Number of subjects: 46
Study 1621413 — intervention group
Group type: COMPARATOR
Intervention: Saline intranasal administration
Number of subjects: 46
Study 6147641 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofibrate
Number of subjects: 208000
Study 6147641 — intervention group
Group type: COMPARATOR
Intervention: High cholesterol control group
Number of subjects: 208000
Study 31730401 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAMSI-TCM questionnaire
Number of subjects: 38
Study 31730401 — intervention group
Group type: COMPARATOR
Intervention: CONTROL questionnaire
Number of subjects: 38
Study 31730401 — intervention group
Group type: EXPERIMENTAL
Intervention: Training in TEAMSI-TCM
Number of subjects: 38
Study 31730401 — intervention group
Group type: COMPARATOR
Intervention: Training in CONTROL
Number of subjects: 38
Study 28001493 — intervention group
Group type: EXPERIMENTAL
Intervention: Video modeling intervention over 6 weeks
Number of subjects: 61
Study 28001493 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment control group
Number of subjects: 61
Study 26866433 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 4 mg after tracheal intubation and ondansetron 4 mg during skin closure
Number of subjects: 117
Study 26866433 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117
Study 26866433 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone and ondansetron
Number of subjects: 117
Study 24419137 — intervention group
Group type: EXPERIMENTAL
Intervention: MicroRNA signature classifier (MSC)
Number of subjects: 939
Study 24419137 — intervention group
Group type: COMPARATOR
Intervention: Low-dose computed tomography (LDCT)
Number of subjects: 939
Study 24419137 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of MSC and LDCT
Number of subjects: 939
Study 24419137 — intervention group
Group type: EXPERIMENTAL
Intervention: MicroRNA signature classifier (MSC) risk groups
Number of subjects: 939
Study 22429268 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil plus bevacizumab (1.25 mg/0.05 mL)
Number of subjects: 43
Study 22429268 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil only (7.5 mg/0.15 mL)
Number of subjects: 43
Study 22429268 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-fluorouracil plus bevacizumab
Number of subjects: 43
Study 22429268 — intervention group
Group type: COMPARATOR
Intervention: 5-fluorouracil only
Number of subjects: 43
Study 19585925 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitored nutritional regimen (study group)
Number of subjects: 257
Study 19585925 — intervention group
Group type: COMPARATOR
Intervention: Conventional prenatal dietary management (control group)
Number of subjects: 257
Study 17233688 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychiatric intervention (treatment study)
Number of subjects: 293
Study 17233688 — intervention group
Group type: COMPARATOR
Intervention: Psychological intervention (prevention study)
Number of subjects: 293
Study 17233688 — intervention group
Group type: COMPARATOR
Intervention: Functional tests for mobility and pain measures
Number of subjects: 293
Study 14649347 — intervention group
Group type: EXPERIMENTAL
Intervention: TIVA with ketamine-midazolam (KM)
Number of subjects: 50
Study 14649347 — intervention group
Group type: COMPARATOR
Intervention: halothane-nitrous oxide-oxygen anaesthesia
Number of subjects: 50
Study 10971683 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (one tablet qds) + amoxicillin (500 mg qds) + metronidazole (400 mg tds)
Number of subjects: 120
Study 10971683 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subnitrate (two tablets tds) + amoxicillin (500 mg qds) + metronidazole (400 mg tds)
Number of subjects: 120
Study 10971683 — intervention group
Group type: COMPARATOR
Intervention: Placebo bismuth (two tablets tds) + amoxicillin (500 mg qds) + metronidazole (400 mg tds)
Number of subjects: 120
Study 10971683 — intervention group
Group type: COMPARATOR
Intervention: Bismuth subnitrate (two tablets tds) + placebo antibiotics
Number of subjects: 120
Study 8967617 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentaglobin therapy (Group 1)
Number of subjects: 55
Study 8967617 — intervention group
Group type: COMPARATOR
Intervention: No immunoglobulin therapy (Group 2)
Number of subjects: 55
Study 1474536 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabumetone (1000 mg/day)
Number of subjects: 197
Study 1474536 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin (75 mg/day)
Number of subjects: 197
Study 6439566 — intervention group
Group type: EXPERIMENTAL
Intervention: SUL (1 mg/kg i.m.)
Number of subjects: 7
Study 6439566 — intervention group
Group type: COMPARATOR
Intervention: SUL + PL (2 ml saline i.v.)
Number of subjects: 7
Study 6439566 — intervention group
Group type: EXPERIMENTAL
Intervention: SUL + TRH (200 mcg i.v.)
Number of subjects: 7
Study 6439566 — intervention group
Group type: COMPARATOR
Intervention: TRH (200 mcg i.v.)
Number of subjects: 7
Study 31735388 — intervention group
Group type: EXPERIMENTAL
Intervention: Freestyle bioprosthesis (N = 90)
Number of subjects: 166
Study 31735388 — intervention group
Group type: COMPARATOR
Intervention: Homograft (N = 76)
Number of subjects: 166
Study 28137402 — intervention group
Group type: EXPERIMENTAL
Intervention: Swiss ball exercises with free weights, performed two times per week for 16 weeks
Number of subjects: 60
Study 28137402 — intervention group
Group type: EXPERIMENTAL
Intervention: Swiss ball exercises
Number of subjects: 60
Study 28137402 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 60
Study 26463489 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin (400 mg qd)
Number of subjects: 202
Study 26463489 — intervention group
Group type: COMPARATOR
Intervention: Cefoperazone-sulbactam (3.0 q 8 h)
Number of subjects: 202
Study 23379974 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidaxomicin (200 mg twice daily for 10 days)
Number of subjects: 999
Study 23379974 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin (125 mg 4 times daily for 10 days)
Number of subjects: 999
Study 23379974 — intervention group
Group type: EXPERIMENTAL
Intervention: Advancing age (in 10‐year increments)
Number of subjects: 999
Study 23379974 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Number of subjects: 999
Study 21333599 — intervention group
Group type: EXPERIMENTAL
Intervention: Kyphoplasty
Number of subjects: 134
Study 21333599 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical management (Control)
Number of subjects: 134
Study 19962185 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV‐16/18 AS04‐adjuvanted vaccine
Number of subjects: 1113
Study 19962185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1113
Study 16702779 — intervention group
Group type: EXPERIMENTAL
Intervention: High intensity strength training for 10 weeks
Number of subjects: 27
Study 16702779 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 27
Study 16825847 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (once a day for 3 days, 30-60 minutes per day)
Number of subjects: 40
Study 16825847 — intervention group
Group type: COMPARATOR
Intervention: Control (no music therapy)
Number of subjects: 40
Study 10822122 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural block
Number of subjects: 455
Study 10822122 — intervention group
Group type: COMPARATOR
Intervention: Nonrandomized patients
Number of subjects: 455
Study 8675168 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA (15 mg/kg body weight daily) plus taurine (30 mg/kg body weight daily)
Number of subjects: 55
Study 8675168 — intervention group
Group type: EXPERIMENTAL
Intervention: UDCA plus placebo
Number of subjects: 55
Study 8675168 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplementation
Number of subjects: 55
Study 8675168 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 1325328 — intervention group
Group type: EXPERIMENTAL
Intervention: High diet
Number of subjects: 14
Study 1325328 — intervention group
Group type: EXPERIMENTAL
Intervention: Low diet
Number of subjects: 14
Study 1325328 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in dietary intake of 9,11-octadecadienoic acid
Number of subjects: 14
Study 6152275 — intervention group
Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 9
Study 29903635 — intervention group
Group type: EXPERIMENTAL
Intervention: New technique (NM) - compression with 2 thumbs with closed fists
Number of subjects: 0
Study 29903635 — intervention group
Group type: COMPARATOR
Intervention: Classical technique (MT)
Number of subjects: 0
Study 29903635 — intervention group
Group type: EXPERIMENTAL
Intervention: New technique (NM)
Number of subjects: 0
Study 30355117 — intervention group
Group type: EXPERIMENTAL
Intervention: IVT+MT
Number of subjects: 381
Study 30355117 — intervention group
Group type: EXPERIMENTAL
Intervention: IVT+MT (in patients without anticoagulant medication before stroke onset)
Number of subjects: 381
Study 30355117 — intervention group
Group type: COMPARATOR
Intervention: MT alone
Number of subjects: 381
Study 27716123 — intervention group
Group type: EXPERIMENTAL
Intervention: Bandage contact lens (BCL) application (n=14)
Number of subjects: 26
Study 27716123 — intervention group
Group type: COMPARATOR
Intervention: No BCL application (control group, n=12)
Number of subjects: 26
Study 24884885 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of folic acid (FA) daily
Number of subjects: 1000
Study 24884885 — intervention group
Group type: COMPARATOR
Intervention: 0.4 mg of folic acid (FA) daily
Number of subjects: 1000
Study 23157895 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral treatment with naltrexone (22-week comprehensive intervention)
Number of subjects: 40
Study 20201661 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual laser ablation of urethral strictures (VLASU) with Nd:YAG laser
Number of subjects: 50
Study 20201661 — intervention group
Group type: COMPARATOR
Intervention: Sachse's optical urethrotomy
Number of subjects: 50
Study 19378423 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (400 mg vitamin C and 180 mg vitamin E d(‐1) and 200 mg BiO‐Quinon Q10 d(‐1))
Number of subjects: 18
Study 19378423 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 15973918 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol MCT/LCT
Number of subjects: 40
Study 15973918 — intervention group
Group type: COMPARATOR
Intervention: Propofol LCT
Number of subjects: 40
Study 15339559 — intervention group
Group type: EXPERIMENTAL
Intervention: Jianpi Huoxue Jiedu (JPHXJD) prescription combined with chemotherapy
Number of subjects: 0
Study 15339559 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy
Number of subjects: 0
Study 10229744 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 3
Study 10229744 — intervention group
Group type: EXPERIMENTAL
Intervention: Trandolapril
Number of subjects: 3
Study 10229744 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Verapamil and Trandolapril
Number of subjects: 3
Study 10229744 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 3
Study 8722437 — intervention group
Group type: EXPERIMENTAL
Intervention: Diuretic (chlorthalidone)
Number of subjects: 40000
Study 8722437 — intervention group
Group type: COMPARATOR
Intervention: Calcium antagonist (amlodipine)
Number of subjects: 40000
Study 8722437 — intervention group
Group type: COMPARATOR
Intervention: Angiotensin converting enzyme inhibitor (lisinopril)
Number of subjects: 40000
Study 8722437 — intervention group
Group type: COMPARATOR
Intervention: Alpha-adrenergic blocker (doxazosin)
Number of subjects: 40000
Study 8722437 — intervention group
Group type: EXPERIMENTAL
Intervention: HMG CoA reductase inhibitor (pravastatin)
Number of subjects: 40000
Study 8722437 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40000
Study 1883797 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethamsylate
Number of subjects: 34
Study 1883797 — intervention group
Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 34
Study 31421679 — intervention group
Group type: EXPERIMENTAL
Intervention: Palonosetron
Number of subjects: 140
Study 31421679 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 140
Study 27955918 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (50 µg) added to lidocaine (9.5 mL) and ropivacaine (10 mL)
Number of subjects: 60
Study 27955918 — intervention group
Group type: COMPARATOR
Intervention: Saline (0.5 mL) added to lidocaine (9.5 mL) and ropivacaine (10 mL)
Number of subjects: 60
Study 25811668 — intervention group
Group type: EXPERIMENTAL
Intervention: Commercial kit with 125I-21OH
Number of subjects: 102
Study 25811668 — intervention group
Group type: EXPERIMENTAL
Intervention: In-house assay (n=9) using in vitro-translated 35S-21OH or luciferase-labeled 21OH
Number of subjects: 102
Study 25811668 — intervention group
Group type: COMPARATOR
Intervention: All laboratories (14 total)
Number of subjects: 102
Study 25811668 — intervention group
Group type: COMPARATOR
Intervention: In-house laboratories (n=9)
Number of subjects: 102
Study 25811668 — intervention group
Group type: COMPARATOR
Intervention: Commercial kit users (n=5)
Number of subjects: 102
Study 25811668 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized cutoff levels
Number of subjects: 102
Study 23929441 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive intervention (social and problem-solving skills training for boys and training for parents on effective child-rearing skills)
Number of subjects: 172
Study 23929441 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 172
Study 21111770 — intervention group
Group type: EXPERIMENTAL
Intervention: Er:YAG laser (Kavo)
Number of subjects: 9
Study 21111770 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary/oscillating instruments
Number of subjects: 9
Study 21111770 — intervention group
Group type: EXPERIMENTAL
Intervention: CeraBur (Komet-Brasseler)
Number of subjects: 9
Study 21111770 — intervention group
Group type: EXPERIMENTAL
Intervention: Cariex (Kavo)
Number of subjects: 9
Study 21111770 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemo-mechanical excavation with conventional metal excavators (Carisolv, MediTeam; exp. SFC-V and SFC-VIII, 3M-ESPE)
Number of subjects: 9
Study 21111770 — intervention group
Group type: EXPERIMENTAL
Intervention: Plastic excavator with exp. SFC-VIII
Number of subjects: 9
Study 19158226 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 microg/d cholecalciferol (D3) supplementation
Number of subjects: 112
Study 19158226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study 17453654 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocolized pharmacotherapy with nortriptyline
Number of subjects: 126
Study 17453654 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocolized pharmacotherapy with nortriptyline-plus-lithium
Number of subjects: 126
Study 17453654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 17453654 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 126
Study 15189389 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of IHD guidelines
Number of subjects: 32
Study 15189389 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin, beta-blockers, and angiotensin converting enzyme inhibitors
Number of subjects: 32
Study 15189389 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline adherence
Number of subjects: 32
Study 11699982 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial agents for caries management
Number of subjects: 0
Study 11699982 — intervention group
Group type: COMPARATOR
Intervention: Antimicrobial agents
Number of subjects: 0
Study 9688168 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil capsules containing 1.5 g DHA
Number of subjects: 46
Study 9688168 — intervention group
Group type: COMPARATOR
Intervention: Control oil capsules containing 97% soybean oil plus 3% of another fish oil
Number of subjects: 46
Study 7857355 — intervention group
Group type: EXPERIMENTAL
Intervention: Pidotimod
Number of subjects: 580